Department of Pathophysiology, Neuroscience Research Center, Hebei Medical University, Shijiazhuang City, People's Republic of China.
Central Laboratory, The Second Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
J Neurochem. 2023 Jul;166(2):215-232. doi: 10.1111/jnc.15874. Epub 2023 Jun 7.
Abnormal activation of the extrasynaptic N-methyl-d-aspartate receptor (NMDAR) contributes to the pathogenesis of Alzheimer's disease (AD). Ceftriaxone (Cef) can improve cognitive impairment by upregulating glutamate transporter-1 and promoting the glutamate-glutamine cycle in an AD mouse model. This study aimed to investigate the effects of Cef on synaptic plasticity and cognitive-behavioral impairment and to unravel the associated underlying mechanisms. We used an APPswe/PS1dE9 (APP/PS1) mouse model of AD in this study. Extrasynaptic components from hippocampal tissue homogenates were isolated using density gradient centrifugation. Western blot was performed to evaluate the expressions of extrasynaptic NMDAR and its downstream elements. Intracerebroventricular injections of adeno-associated virus (AAV)-striatal enriched tyrosine phosphatase 61 (STEP ) and AAV-STEP -shRNA were used to modulate the expressions of STEP and extrasynaptic NMDAR. Long-term potentiation (LTP) and Morris water maze (MWM) tests were performed to evaluate the synaptic plasticity and cognitive function. The results showed that the expressions of GluN2B and GluN2B in the extrasynaptic fraction were upregulated in AD mice. Cef treatment effectively prevented the upregulation of GluN2B and GluN2B expressions. It also prevented changes in the downstream signals of extrasynaptic NMDAR, including increased expressions of m-calpain and phosphorylated p38 MAPK in AD mice. Furthermore, STEP upregulation enhanced, whereas STEP downregulation reduced the Cef-induced inhibition of the expressions of GluN2B, GluN2B , and p38 MAPK in the AD mice. Similarly, STEP modulation affected Cef-induced improvements in induction of LTP and performance in MWM tests. In conclusion, Cef improved synaptic plasticity and cognitive behavioral impairment in APP/PS1 AD mice by inhibiting the overactivation of extrasynaptic NMDAR and STEP cleavage due to extrasynaptic NMDAR activation.
异常激活细胞外 N-甲基-D-天冬氨酸受体 (NMDAR) 参与阿尔茨海默病 (AD) 的发病机制。头孢曲松 (Cef) 通过上调谷氨酸转运体-1 和促进 AD 小鼠模型中的谷氨酸-谷氨酰胺循环来改善认知障碍。本研究旨在研究 Cef 对突触可塑性和认知行为障碍的影响,并揭示相关的潜在机制。在这项研究中,我们使用了 APPswe/PS1dE9 (APP/PS1) AD 小鼠模型。使用密度梯度离心从海马组织匀浆中分离细胞外突触成分。通过 Western blot 评估细胞外 NMDAR 及其下游元件的表达。使用脑室内注射腺相关病毒 (AAV)-纹状体富集的酪氨酸磷酸酶 61 (STEP) 和 AAV-STEP-shRNA 来调节 STEP 和细胞外 NMDAR 的表达。进行长时程增强 (LTP) 和 Morris 水迷宫 (MWM) 测试以评估突触可塑性和认知功能。结果表明,AD 小鼠细胞外突触部分的 GluN2B 和 GluN2B 表达上调。Cef 治疗可有效阻止 GluN2B 和 GluN2B 表达的上调。它还可防止细胞外 NMDAR 下游信号的改变,包括 AD 小鼠中 m-calpain 和磷酸化 p38 MAPK 表达增加。此外,STEP 上调增强,而 STEP 下调减少了 Cef 诱导的 AD 小鼠中 GluN2B、GluN2B 和 p38 MAPK 表达的抑制。同样,STEP 调节影响 Cef 诱导的 LTP 诱导和 MWM 测试中的表现改善。总之,Cef 通过抑制由于细胞外 NMDAR 激活导致的细胞外 NMDAR 过度激活和 STEP 切割,改善了 APP/PS1 AD 小鼠的突触可塑性和认知行为障碍。